Creighton University
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Creighton University sits in the top decile of US sponsors by registered trial count (#243 of 15,742 sponsors by registered trial count).
Creighton University: 98 sponsored US clinical trials, 5 recruiting.
Creighton University sponsors 98 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 85 completed. 21 of these trials are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Osteopenia, with 2 trials.
Top-decile sponsor footprint
Creighton University ranks in the top decile of sponsors by registered trial count (#243 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
85 of 92 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
98 total, page 1 of 2
Subthreshold Vestibular Stimulation as a Strategy for Rehabilitation
NCT06732440
Improving Exercise Adherence With App Technology for At-Risk Adults Living in Rural Kansas and Nebraska
NCT07171255
The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia
NCT06853275
Improving Physical Activity With Cognitive Impairment
NCT05370118
Skeletal Effects of Type 1 Diabetes on Low-Trauma Fracture Risk
NCT05701254
High-Intensity Interval Training for Older Adults
NCT05542758
High-Intensity Interval Training in a Community Gym
NCT06976060
Cognitive Behavioral Based Physical Therapy for Patients With Chronic Ankle Instability
NCT07237581
A Telehealth Lifestyle Intervention for Community-Dwelling Older Adults
NCT05462626
Effectiveness of a 6-week Hippotherapy Program in Children With Autism Spectrum Disorder
NCT04772898
Telehealth Family Coaching With Type 1 Diabetes
NCT04753099
3D Maternal Fetal Bonding
NCT04540458
Third Trimester 3D Printed Models Versus 3D Ultrasound Effects on Maternal-Fetal Attachment
NCT03883971
Attention Control Training for PTSD in Children
NCT03348540
Attention Control Training for PTSD Related to Combat or Interpersonal Violence
NCT03350360
Finances First: A Health Intervention in Low Income Single Mother Households
NCT03035240
Characterizing Clinical and Biomechanical Contributions to Function Following ACL Reconstruction
NCT03132987
Impact of Fatigue on Jumping Performance
NCT03133078
Radiographic Contrast To Differentiate Cavitated From Non-cavitated Tooth Decay
NCT02359279
The Impact of a Heart Failure Review on Self-Care Knowledge, Adherence and Clinical Outcomes
NCT02415751
The Influence of Vitamin D on Atypical Antipsychotic-induced Weight Gain
NCT02281162
Corticospinal Excitability and Rehab in Knee Osteoarthritis
NCT02036866
Motor and Sensory Deficits Following Partial Meniscectomy
NCT02100059
e-Cigarettes Versus NRT Gum for Smoking Cessation
NCT01925781
Physiological Response of Cortisol to Cardiac Catheterization
NCT01822847
Breast Cancer, Aromatase Inhibitor Therapy, and Sexual Functioning: The Effects of Vaginal Testosterone Therapy
NCT01697345
Neuromuscular Consequences of Knee Arthroscopy
NCT01786772
Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney Disease Patients on Chronic Hemodialysis
NCT01675557
Type 1 Diabetes Mellitus Effect on Bone Mineral Density
NCT01633684
PRospective Evaluation of Electrocardiographic Voltage Changes and Six Minute Walk Test for Predicting Readmissions in Heart Failure (PREEMT-HF Study)
NCT01675544
Hatha Yoga for Smoking Cessation
NCT01633632
Use of Radiographic Contrast to Detect Dental Caries
NCT01523509
Type 1 Diabetes Mellitus Bone Mineral Density in Childhood and Adolescence
NCT01605149
B-type Natriuretic Peptide as a Surrogate Marker Guiding Post-operative Fluid Off-loading
NCT01584518
Skin Blood Flow in Patients With Type 1 Diabetes Mellitus Compared to Normal Controls
NCT01592539
Attention Bias Modification Treatment for Warzone-Related Posttraumatic Stress Disorder (PTSD)
NCT01564667
Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation
NCT01513031
Effects of Thoracic Mobilization on Shoulder Range of Motion
NCT01518504
Changes in Quadriceps Function Following Local or Distant Interventions in Individuals With Patellofemoral Pain
NCT01434966
Effect of Joint Mobilization in the Treatment of Chronic Ankle Instability
NCT01438905
Impact of a Financial Success Education Program in Women and Children
NCT01409291
Web-based Education on Oral Cancer for Primary Care Physicians in Ohio
NCT01424358
Aspirin Responsiveness in Women With Coronary Artery Disease
NCT01406990
Study of Echocardiogram Accuracy in Patients With Mitral Valve Calcification
NCT01442467
Vitamin D Effect on Calcium Absorption on Persons on Hemodialysis
NCT01325610
Effects of Ankle Support on Muscle Activation and Function
NCT01423513
Effects of Intranasal Corticosteroid and Montelukast On Nasal Allergen Challenges*
NCT01240889
Environmental & Genetic Influences on Vitamin D Status
NCT01208636
Radial Versus Femoral Arterial Access for Cardiac Catheterization: Comparison of Complications at 30 Days
NCT01019330
Vitamin D and T-Regulatory Cells in Coronary Artery Disease
NCT01183962
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 3 | 3 |
| Phase 4 | 18 |
Where Creighton University enrollment is open (later-stage tilt)
5 recruiting of 98 indexed (5% open); 85 completed (87%).
Phase mix: 21 late (III/IV) vs 7 early (I/II) (later-stage heavy).
Top condition: Osteopenia (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Creighton University: open-pipeline peers nationwide
Peers matched on 98 registered trials and 5% open enrollment, not the therapeutic-area sidebar.
Creighton University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 98 trials (± recruiting share)
- GE Healthcare · 99 trials · 8% recruiting
- Arkansas Children's Hospital Research Institute · 97 trials · 19% recruiting
- UCB Pharma · 100 trials · 0% recruiting
- Wake Forest University · 100 trials · 7% recruiting
Sponsors near 5% open enrollment (± trial volume)
- Gilead Sciences · 5% recruiting · 504 trials
- Avera McKennan Hospital & University Health Center · 5% recruiting · 20 trials
- HonorHealth Research Institute · 5% recruiting · 20 trials
- Integra LifeSciences Corporation · 5% recruiting · 60 trials
Related
What to do with this Creighton University page
98 registered trials is a research-attention snapshot, not an endorsement of Creighton University or any single study.
- 5 of Creighton University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Osteopenia is the condition Creighton University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Osteopenia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Creighton University pipeline card: 98 registered trials from official public datasets.Report a data error.